n-isopropylacrylamide has been researched along with Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CY; Chen, CH; Chen, JP; Chen, SH; Kuo, CY; Mao, SH; Shalumon, KT | 1 |
| Anwar, MF; Asif, M; Beg, MN; Garg, V; Gaur, S; Kardam, H; Suri, S; Yadav, D | 1 |
2 other study(ies) available for n-isopropylacrylamide and Carcinoma
| Article | Year |
|---|---|
Thermosensitive Injectable Hydrogel for Simultaneous Intraperitoneal Delivery of Doxorubicin and Prevention of Peritoneal Adhesion.
Topics: Acrylamides; Animals; Carcinoma; Cell Line, Tumor; Colonic Neoplasms; Doxorubicin; Drug Delivery Systems; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Hydrogels; Mice; Mice, Inbred BALB C; Peritoneal Neoplasms; Peritoneum; Tissue Adhesions | 2018 |
Development of polymeric nanopaclitaxel and comparison with free paclitaxel for effects on cell proliferation of MCF-7 and B16F0 carcinoma cells.
Topics: Acrylamides; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cell Survival; Delayed-Action Preparations; Drug Carriers; Humans; MCF-7 Cells; Melanoma, Experimental; Nanoparticles; Paclitaxel; Particle Size; Polymers | 2014 |